Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4.15p
   
  • Change Today:
      0.23p
  • 52 Week High: 11.25p
  • 52 Week Low: 2.40p
  • Currency: UK Pounds
  • Shares Issued: 697.20m
  • Volume: 5,544,421
  • Market Cap: £28.93m

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest Deals

Traded Action Notifier PriceAmountValue
25-Jun-25 Buy Cathal Friel 2.50p 4,000,000 £100,000.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
25-Jun-25 Buy Cathal Friel 2.50p 4,000,000 £100,000.00

Director Shareholdings

Notifier Holding Value*
Cathal Friel 41,219,757 £1,710,620
Ian O’Connel 8,326,839 £345,564
Jeremy Skillington 1,028,261 £42,673

Major Shareholders

Notifier** Holding Value*
Roaring Waters Capital 40,000,000 £1,660,000
Michael Kelly 35,443,132 £1,470,890
Schroder Investment Management 24,994,777 £1,037,283
Allan Rankin 16,216,038 £672,966

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 4.15p
Change Today 0.23p
% Change 5.73 %
52 Week High 11.25p
52 Week Low 2.40p
Volume 5,544,421
Shares Issued 697.20m
Market Cap £28.93m

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
53.79% below the market average53.79% below the market average53.79% below the market average53.79% below the market average53.79% below the market average
7.32% below the sector average7.32% below the sector average7.32% below the sector average7.32% below the sector average7.32% below the sector average
Price Trend
87.96% below the market average87.96% below the market average87.96% below the market average87.96% below the market average87.96% below the market average
77.27% below the sector average77.27% below the sector average77.27% below the sector average77.27% below the sector average77.27% below the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 08-Sep-2025

Time Volume / Share Price
17:07 110,000 @ 4.15p
16:27 12,554 @ 4.15p
16:22 250,000 @ 4.15p
16:20 100,000 @ 4.15p
16:18 4,407 @ 4.27p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page